Company:  PASITHEA THERAPEUTICS COR ... (KTTA)
Form Type:  3
Filing Date:  9/14/2021 
CIK:  0001841330 
Address:  2110 NARCISSUS CT 
City, State, Zip:  VENICE, California 90291 
Telephone:  (818) 422-6172 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$2.98  
Change: 
0.07 (2.41%)  
Trade Time: 
Oct 15  
Market Cap: 
$38.91M
Trade KTTA now with 

© 2021  
Description of Business
We are a biotechnology company focused on the research and discovery of new and effective treatments for psychiatric and neurological disorders. Epidemiological data indicate neuropsychiatric disorders as being some of the most prevalent, devastating, and yet poorly treated illnesses. We believe that the current treatments for these disorders, such as depression, are inadequate and that conventional medicines have low success rates in long-term treatment. According to an article published by PLOS One, randomized, double-blind, placebo-controlled clinical trials of antidepressants were only effective for 42-51% of patients with MDD. For example, current pharmacotherapies for MDD and BDep have a distinct lag of onset that can generate further distress and impairment in patients.
Register and access this filing in:     
  FORM 3
    NAME AND TITLE
    NON DERIVATIVE SECURITIES
    DERIVATIVE SECURITIES
    REPORTING OWNERS
    SIGNATURES